Join to View Full Profile
15000 Midlantic DrSuite 100Mount Laurel, NJ 08054
Phone+1 877-388-2778
Dr. Asroff is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Scott Asroff, MD, is a urologist based in Mount Laurel, NJ, with a focus on urologic oncology, minimally invasive surgeries, and robotic and laparoscopic techniques. He completed his medical education at the Lewis Katz School of Medicine at Temple University and went on to complete residencies in surgery and urology at Brown University. Dr. Asroff has contributed to various publications, including studies on urinary tests and prostate cancer detection, with his work being cited multiple times in the academic community. He is recognized with accolades such as the Meaningful Use Stage 1 Certification and is a Fellow of the American College of Surgeons.
Education & Training
Rhode Island Hospital/Brown University HealthResidency, Urology, 1988 - 1991- Rhode Island Hospital/Brown University HealthResidency, Surgery, 1986 - 1988
Lewis Katz School of Medicine at Temple UniversityClass of 1986
Certifications & Licensure
FL State Medical License 2021 - 2027
NJ State Medical License 1991 - 2027
PA State Medical License 1999 - 2006
American Board of Urology Urology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
- Fellow (FACS) American College of Surgeons
Publications & Presentations
PubMed
- 8 citationsUrinary Analysis ofandGene Mutations Enhances Performance of Cxbladder Tests and Improves Patient Risk Stratification.Yair Lotan, Jay D Raman, Badrinath Konety, Siamak Daneshmand, Florian Schroeck
The Journal of Urology. 2023-04-01 - 96 citationsClinical comparison of noninvasive urine tests for ruling out recurrent urothelial carcinoma.Yair Lotan, Paul OʼSullivan, Jay D. Raman, Sharokh F. Shariat, Laimonis Kavalieris
Urologic Oncology. 2017-08-01 - 282 citationsA Multi-institutional Prospective Trial in the USA Confirms that the 4Kscore Accurately Identifies Men with High-grade Prostate CancerDipen J. Parekh, Sanoj Punnen, Daniel Sjöberg, Scott Asroff, James Bailen
European Urology. 2015-09-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
